Effect Modifier, Epidemiologic
"Effect Modifier, Epidemiologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Factors that modify the effect of the putative causal factor(s) under study.
Descriptor ID |
D015987
|
MeSH Number(s) |
N05.715.350.350 N06.850.490.734
|
Concept/Terms |
Effect Modifier, Epidemiologic- Effect Modifier, Epidemiologic
- Modifier, Epidemiologic Effect
- Effect Modifiers, Epidemiologic
- Modifiers, Epidemiologic Effect
- Epidemiologic Effect Modifiers
- Moderator Variables
- Moderator Variable
- Variable, Moderator
- Variables, Moderator
- Conditional Variables
- Conditional Variable
- Variable, Conditional
- Variables, Conditional
- Epidemiologic Effect Modifier
Interviewer Effect- Interviewer Effect
- Effect, Interviewer
- Effects, Interviewer
- Interviewer Effects
Halo Effect- Halo Effect
- Effect, Halo
- Effects, Halo
- Halo Effects
|
Below are MeSH descriptors whose meaning is more general than "Effect Modifier, Epidemiologic".
Below are MeSH descriptors whose meaning is more specific than "Effect Modifier, Epidemiologic".
This graph shows the total number of publications written about "Effect Modifier, Epidemiologic" by people in this website by year, and whether "Effect Modifier, Epidemiologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Effect Modifier, Epidemiologic" by people in Profiles.
-
Ziyab AH, Karmaus W, Zhang H, Holloway JW, Steck SE, Ewart S, Arshad SH. Association of filaggrin variants with asthma and rhinitis: is eczema or allergic sensitization status an effect modifier? Int Arch Allergy Immunol. 2014; 164(4):308-18.
-
Berenz EC, Trapp SK, Acierno R, Richardson L, Kilpatrick DG, Tran TL, Trung LT, Tam NT, Tuan T, Buoi LT, Ha TT, Thach TD, Gaboury M, Amstadter AB. Pretyphoon panic attack history moderates the relationship between degree of typhoon exposure and posttyphoon PTSD and depression in a Vietnamese sample. Depress Anxiety. 2013 May; 30(5):461-8.
-
Carey TS, Williams JW, Oldham JM, Goodman F, Ranney LM, Whitener L, Morgan LC, Melvin CL. Gabapentin in the treatment of mental illness: the echo chamber of the case series. J Psychiatr Pract. 2008 Mar; 14 Suppl 1:15-27.
-
Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol. 2007 Mar 01; 165(5):514-23.
-
Arani RB, Soong SJ, Weiss HL, Wood MJ, Fiddian PA, Gnann JW, Whitley R. Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med. 2001 Aug 30; 20(16):2429-39.
-
Dorn JP, Cerny FJ, Epstein LH, Naughton J, Vena JE, Winkelstein W, Schisterman E, Trevisan M. Work and leisure time physical activity and mortality in men and women from a general population sample. Ann Epidemiol. 1999 Aug; 9(6):366-73.
-
Akazawa K, Nakamura T, Palesch Y. Power of logrank test and Cox regression model in clinical trials with heterogeneous samples. Stat Med. 1997 Mar 15; 16(5):583-97.
-
Pellegrin KL, Carek D, Edwards J. Use of experimental and quasi-experimental methods for data-based decisions in QI. Jt Comm J Qual Improv. 1995 Dec; 21(12):683-91.